Immediate Impact

58 standout
Sub-graph 1 of 24

Citing Papers

Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
2025 Standout
4 intermediate papers

Works of Alexia Kieffer being referenced

Incidence of respiratory syncytial virus related health care utilization in the United States
2020
Trends in healthcare utilization and costs associated with pneumonia in the United States during 2008–2014
2018
and 1 more

Author Peers

Author Last Decade Papers Cites
Alexia Kieffer 421 186 165 36 612
Alexis Rybak 276 171 108 30 536
Cissy B. Kartasasmita 331 103 166 65 619
Laura Toivonen 395 213 139 38 703
Pekka Honkanen 543 100 54 24 682
Þórólfur Guðnason 387 49 125 41 595
Parveen Fathima 422 102 156 47 568
Fernanda Rodrigues 376 67 148 65 653
Jean‐Yves Pirçon 433 197 333 24 717
Ufuk Beyazova 265 48 109 47 723
Cristian Launes 414 113 224 56 636

All Works

Loading papers...

Rankless by CCL
2026